What are the effects of antifibrotic medications on the progression of chronic kidney disease related to nephropathy?

Read full text Summarise with VIRAT
Authors: Tripdatabase
Cited by: 0

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

Antifibrotic medications may influence the progression of CKD by targeting fibrosis, as shown in preclinical models, but more clinical data is needed to confirm their efficacy in humans.

Fields of Study & Subjects

Chronic Kidney Disease and Diabetes Renal Diseases and Glomerulopathies Acute Kidney Injury Research

Publication details

Journal / source
Zenodo (CERN European Organization for Nuclear Research)
Publication date
25 March 2026
Language
EN